Abundant and diverse clustered regularly interspaced short palindromic repeat spacers in Clostridium difficile strains and prophages target multiple phage types within this pathogen

mBio

Volumn 5, Issue 5, 2014, Pages

  Hargreaves, Katherine R ^a   Flores, Cesar O ^b   Lawley, Trevor D ^c   Clokie, Martha R J ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLOSTRIDIUM DIFFICILE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; GENE FUNCTION; GENETIC ANALYSIS; GENETIC CONSERVATION; GENETIC VARIABILITY; MICROBIAL DIVERSITY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; POPULATION ABUNDANCE; PROPHAGE; BACTERIAL GENOME; BIODIVERSITY; DNA SEQUENCE; GENETICS; METABOLISM; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MUTATION; PEPTOCLOSTRIDIUM DIFFICILE; SEQUENCE ALIGNMENT;

CLOSTRIDIUM DIFFICILE;

TRANSCRIPTOME;

BASE SEQUENCE; BIODIVERSITY; CLOSTRIDIUM DIFFICILE; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; EVOLUTION, MOLECULAR; GENOME, BACTERIAL; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; MUTATION; PROPHAGES; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME;

EID: 84908432854     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.01045-13     Document Type: Article

References (79)

1. Bouza E. 2012. Consequences of Clostridium difficile infection: understanding the healthcare burden. Clin. Microbiol. Infect. 18:5-12. http:// dx.doi.org/10.1111/j.1469-0691.2012.03862.x.
2. Hall IC, O'Toole E. 1935. Intestinal flora in new-born infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am. J. Dis. Child. 49:390 - 402. http://dx.doi.org/10.1001/archpedi.1935.01970020105010.
3. al Saif N, Brazier JS. 1996. The distribution of Clostridium difficile in the environment of South Wales. J. Med. Microbiol. 45:133-137. http:// dx.doi.org/10.1099/00222615-45-2-133.
4. He M, Miyajima F, Roberts P, Ellison L, Pickard DJ, Martin MJ, Connor TR, Harris SR, Fairley D, Bamford KB, D'Arc S, Brazier J, Brown D, Coia JE, Douce G, Gerding D, Kim HJ, Koh TH, Kato H, Senoh M, Louie T, Michell S, Butt E, Peacock SJ, Brown NM, Riley T, Songer G, Wilcox M, Pirmohamed M, Kuijper E, Hawkey P, Wren BW, Dougan G, Parkhill J, Lawley TD. 2013. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45:109-113. http:// dx.doi.org/10.1038/ng.2478.
5. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson NR, Roberts AP, Cerdeño-Tárraga AM, Wang H, Holden MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S, Dupuy B, Dougan G, Barrell B, Parkhill J. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786. http://dx.doi.org/10.1038/ng1830.
6. Siefert JL. 2009. Defining the mobilome. Methods Mol. Biol. 532:13-27. http://dx.doi.org/10.1007/978-1-60327-853-9+2.
7. Goh S, Riley TV, Chang BJ. 2005. Isolation and characterization of temperate bacteriophages of Clostridium difficile. Appl. Environ. Microbiol. 71:1079-1083. http://dx.doi.org/10.1128/AEM.71.2.1079-1083.2005.
8. Goh SH, Hussain H, Chang BJ, Emmett W, Riley TV, Mullany P. 2013. Phage _C2 mediates transduction of Tn6215, encoding erythromycin resistance, between Clostridium difficile strains. mBio 4(6):e00840-13. http:// dx.doi.org/10.1128/mBio.00840-13.
9. Hargreaves KR, Clokie MRJ. 2014. Clostridium difficile phages: still difficult? Front. Microbiol. 5:184. http://dx.doi.org/10.3389/fmicb.2014.00184.
10. Jansen R, Embden JD, Gaastra W, Schouls LM. 2002. Identification of genes that are associated with DNA repeats in prokaryotes. Mol. Microbiol. 43:1565-1575. http://dx.doi.org/10.1046/j.1365-2958.2002.02839.x.
11. Pourcel C, Salvignol G, Vergnaud G. 2005. CRISPR elements in Yersinia pestis acquire new repeats by preferential uptake of bacteriophage DNA, and provide additional tools for evolutionary studies. Microbiology 151: 653-663. http://dx.doi.org/10.1099/mic.0.27437-0.
12. Bolotin A, Quinquis B, Sorokin A, Ehrlich SD. 2005. Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology 151:2551-2561. http://dx.doi.org/ 10.1099/mic.0.28048-0.
13. Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P. 2007. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315:1709-1712. http://dx.doi.org/ 10.1126/science.1138140.
14. Sorek R, Kunin V, Hugenholtz P. 2008. CRISPR-a widespread system that provides acquired resistance against phages in bacteria and archaea. Nat. Rev. Microbiol. 6:181-186. http://dx.doi.org/10.1038/nrmicro1793.
15. Horvath P, Coûté-Monvoisin AC, Romero DA, Boyaval P, Fremaux C, Barrangou R. 2009. Comparative analysis of CRISPR loci in lactic acid bacteria genomes. Int. J. Food Microbiol. 131:62-70. http://dx.doi.org/ 10.1016/j.ijfoodmicro.2008.05.030.
16. Kuno S, Yoshida T, Kaneko T, Sako Y. 2012. Intricate interactions between the bloom-forming cyanobacterium Microcystis aeruginosa and foreign genetic elements, revealed by diversified clustered regularly interspaced short palindromic repeat (CRISPR) signatures. Appl. Environ. Microbiol. 78:5353-5360. http://dx.doi.org/10.1128/AEM.00626-12.
17. Stern A, Mick E, Tirosh I, Sagy O, Sorek R. 2012. CRISPR targeting reveals a reservoir of common phages associated with the human gut microbiome. Genome Res. 22:1985-1994. http://dx.doi.org/10.1101/ gr.138297.112.
18. Barrangou R, Horvath P, Doyle M, Klaenhammer T. 2012. CRISPR. New horizons in phage resistance and strain identification. Annu. Rev. Foods Sci. Technol 3:143-162. http://dx.doi.org/10.1146/annurev-food- 022811-101134.
19. Touchon M, Rocha EP. 2010. The small, slow and specialized CRISPR and anti-CRISPR of Escherichia and Salmonella. PLoS One 5:e11126. http://dx.doi.org/10.1371/journal.pone.0011126.
20. Nozawa T, Furukawa N, Aikawa C, Watanabe T, Haobam B, Kurokawa K, Maruyama F, Nakagawa I. 2011. CRISPR inhibition of prophage acquisition in Streptococcus pyogenes. PLoS One 6:e19543. http:// dx.doi.org/10.1371/journal.pone.0019543.
21. Touchon M, Charpentier S, Clermont O, Rocha EP, Denamur E, Branger C. 2011. CRISPR distribution within the Escherichia coli species is not suggestive of immunity-associated diversifying selection. J. Bacteriol. 193:2460-2467. http://dx.doi.org/10.1128/JB.01307-10.
22. Govind R, Fralick JA, Rolfe RD. 2006. Genomic organization and molecular characterization of Clostridium difficile bacteriophage Phi CD119. J. Bacteriol. 188:2568 -2577. http://dx.doi.org/10.1128/JB.188.7.2568- 2577.2006.
23. Goh S, Ong P, Song K, Riley T, Chang B. 2007. The complete genome sequence of Clostridium difficile phage phi C2 and comparisons to phi CD119 and inducible prophages of CD630. Microbiology 153:676-685. http://dx.doi.org/10.1099/mic.0.2006/002436-0.
24. Horgan M, O'Sullivan O, Coffey A, Fitzgerald GF, van Sinderen D, McAuliffe O, Ross RP. 2010. Genome analysis of the Clostridium difficile phage PhiCD6356, a temperate phage of the Siphoviridae family. Gene 462:34-43. http://dx.doi.org/10.1016/j.gene.2010.04.010.
25. Mayer MJ, Narbad A, Gasson MJ. 2008. Molecular characterization of a Clostridium difficile bacteriophage and its cloned biologically active endolysin. J. Bacteriol. 190:6734-6740. http://dx.doi.org/10.1128/JB.00686- 08.
26. Sekulovic O, Meessen-Pinard M, Fortier LC. 2011. Prophage-stimulated toxin production in Clostridium difficile NAP1/027 lysogens. J. Bacteriol. 193:2726-2734. http://dx.doi.org/10.1128/JB.00787-10.
27. Meessen-Pinard M, Sekulovic O, Fortier LC. 2012. Evidence of in vivo prophage induction during Clostridium difficile infection. Appl. Environ. Microbiol. 78:7662-7670. http://dx.doi.org/10.1128/AEM.02275-12.
28. Hargreaves KR, Colvin HV, Patel KV, Clokie JJ, Clokie MR. 2013. Genetically diverse Clostridium difficile strains harboring abundant prophages in an estuarine environment. Appl. Environ. Microbiol. 79: 6236-6243. http://dx.doi.org/10.1128/AEM.01849-13.
29. Shan J, Patel KV, Hickenbotham PT, Nale JY, Hargreaves KR, Clokie MR. 2012. Prophage carriage and diversity within clinically relevant strains of Clostridium difficile. Appl. Environ. Microbiol. 78:6027-6034. http://dx.doi.org/10.1128/AEM.01311-12.
30. Soutourina OA, Monot M, Boudry P, Saujet L, Pichon C, Sismeiro O, Semenova E, Severinov K, Le Bouguenec C, Coppée JY, Dupuy B, Martin-Verstraete I. 2013. Genome-wide identification of regulatory RNAs in the human pathogen Clostridium difficile. PLoS Genet. 9:e1003493. http://dx.doi.org/10.1371/journal.pgen.1003493.
31. Seed KD, Lazinski DW, Calderwood SB, Camilli A. 2013. A bacteriophage encodes its own CRISPR/Cas adaptive response to evade host innate immunity. Nature 494:489-491. http://dx.doi.org/10.1038/nature11927.
32. Grissa I, Vergnaud G, Pourcel C. 2007. CRISPRFinder: a Web tool to identify clustered regularly interspaced short palindromic repeats. Nucleic Acids Res. 35:W52-W57. http://dx.doi.org/10.1093/nar/gkm360.
33. Grissa I, Vergnaud G, Pourcel C. 2007. The CRISPRdb database and tools to display CRISPRs and to generate dictionaries of spacers and repeats. BMC Bioinformatics 8:172. http://dx.doi.org/10.1186/1471-2105- 8-172.
34. Grissa I, Vergnaud G, Pourcel C. 2008. CRISPRcompar: a website to compare clustered regularly interspaced short palindromic repeats. Nucleic Acids Res. 36:W145-W148. http://dx.doi.org/10.1093/nar/gkn228.
35. Makarova KS, Haft DH, Barrangou R, Brouns SJJ, Charpentier E, Horvath P, Moineau S, Mojica FJ, Wolf YI, Yakunin AF, van der Oost J, Koonin EV. 2011. Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9:467- 477. http://dx.doi.org/10.1038/ nrmicro2577.
36. Kunin V, Sorek R, Hugenholtz P. 2007. Evolutionary conservation of sequence and secondary structures in CRISPR repeats. Genome Biol. 8:R61. http://dx.doi.org/10.1186/gb-2007-8-4-r61.
37. Darling AC, Mau B, Blattner FR, Perna NT. 2004. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 14:1394-1403. http://dx.doi.org/10.1101/gr.2289704.
38. Darling AE, Mau B, Perna NT. 2010. progressiveMauve: multiple genome alignment with gene gain, loss and rearrangement. PLoS One 5:e11147. http://dx.doi.org/10.1371/journal.pone.0011147.
39. Iyer LM, Koonin EV, Aravind L. 2002. Extensive domain shuffling in transcription regulators of DNA viruses and implications for the origin of fungal APSES transcription factors. Genome Biol. 3:R0012. http:// dx.doi.org/10.1186/gb-2002-3-3-research0012.
40. Zemskov EA, Kang W, Maeda S. 2000. Evidence for nucleic acid binding ability and nucleosome association of Bombyx mori nucleopolyhedrovirus BRO proteins. J. Virol. 74:6784 - 6789. http://dx.doi.org/10.1128/ JVI.74.15.6784-6789.2000.
41. Leijonmarck M, Liljas A. 1987. Structure of the C-terminal domain of the ribosomal protein-L7/L12 from Escherichia coli at 1.7 A. J. Mol. Biol. 195: 555-580. http://dx.doi.org/10.1016/0022-2836(87)90183-5.
42. Westra ER, Semenova E, Datsenko KA, Jackson RN, Wiedenheft B, Severinov K, Brouns SJJ. 2013. Type I-E CRISPR-Cas systems discriminate target from non-targetDNAthrough base pairing-independentPAM recognition. PLoS Genet. 9:e1003742. http://dx.doi.org/10.1371/ journal.pgen.1003742.
43. Shah SA, Erdmann S, Mojica FJ, Garrett RA. 2013. Protospacer recog- nition motifs: mixed identities and functional diversity. RNA Biol. 10: 891-899. http://dx.doi.org/10.4161/rna.23764.
44. Vercoe RB, Chang JT, Dy RL, Taylor C, Gristwood T, Clulow JS, Richter C, Przybilski R, Pitman AR, Fineran PC. 2013. Cytotoxic chromosomal targeting by CRISPR/Cas systems can reshape bacterial genomes and expel or remodel pathogenicity islands. PLoS Genet. 9:e1003454. http://dx.doi.org/10.1371/journal.pgen.1003454.
45. Mayer MJ, Garefalaki V, Spoerl R, Narbad A, Meijers R. 2011. Structure-based modification of a Clostridium difficile-targeting endolysin affects activity and host range. J. Bacteriol. 193:5477-5486. http:// dx.doi.org/10.1128/JB.00439-11.
46. Díez-Villaseñor C, Almendros C, García-Martínez J, Mojica FJ. 2010. Diversity of CRISPR loci in Escherichia coli. Microbiology 156:1351-1361. http://dx.doi.org/10.1099/mic.0.036046-0.
47. van der Ploeg JR. 2009. Analysis of CRISPR in Streptococcus mutans suggests frequent occurrence of acquired immunity against infection by M102-like bacteriophages. Microbiology 155:1966 -1976. http:// dx.doi.org/10.1099/mic.0.027508-0.
48. Childs LM, Held NL, Young MJ, Whitaker RJ, Weitz JS. 2012. Multiscale model of CRISPR-induced coevolutionary dynamics: diversification at the interface of Lamarck and Darwin. Evolution 66:2015-2029. http:// dx.doi.org/10.1111/j.1558-5646.2012.01595.x.
49. Ramesh V, Fralick JA, Rolfe RD. 1999. Prevention of Clostridium difficile-induced ileocecitis with bacteriophage. Anaerobe 5:69-78. http:// dx.doi.org/10.1006/anae.1999.0192.
50. Sekulovic O, Garneau JR, Néron A, Fortier L-C. 2014. Characterization of temperate phages infecting Clostridium difficile Isolates from human and animal origin. Appl. Environ. Microbiol. 80:2555-2563. http:// dx.doi.org/10.1128/AEM.00237-14.
51. Bondy-Denomy J, Pawluk A, Maxwell KL, Davidson AR. 2013. Bacteriophage genes that inactivate the CRISPR/Cas bacterial immune system. Nature 493:429-432. http://dx.doi.org/10.1038/nature11723.
52. Essoh C, Blouin Y, Loukou G, Cablanmian A, Lathro S, Kutter E, Thien HV, Vergnaud G, Pourcel C. 2013. The susceptibility of Pseudomonas aeruginosa strains from cystic fibrosis patients to bacteriophages. PLoS One 8:e60575. http://dx.doi.org/10.1371/journal.pone.0060575.
53. Cady KC, Bondy-Denomy J, Heussler GE, Davidson AR, O'Toole GA. 2012. The CRISPR/Cas adaptive immune system of Pseudomonas aeruginosa mediates resistance to naturally occurring and engineered phages. J. Bacteriol. 194:5728-5738. http://dx.doi.org/10.1128/JB.01184-12.
54. Edgar R, Qimron U. 2010. The Escherichia coli CRISPR system protects from lambda lysogenization, lysogens, and prophage induction. J. Bacteriol. 192:6291-6294. http://dx.doi.org/10.1128/JB.00644-10.
55. Semenova E, Jore MM, Datsenko KA, Semenova A, Westra ER, Wanner B, van der Oost J, Brouns SJ, Severinov K. 2011. Interference by clustered regularly interspaced short palindromic repeat (CRISPR) RNA is governed by a seed sequence. Proc. Natl. Acad. Sci. U. S. A. 108: 10098-10103. http://dx.doi.org/10.1073/pnas.1104144108.
56. Minot S, Sinha R, Chen J, Li H, Keilbaugh SA, Wu GD, Lewis JD, Bushman FD. 2011. The human gut virome: inter-individual variation and dynamic response to diet. Genome Res. 21:1616 -1625. http:// dx.doi.org/10.1101/gr.122705.111.
57. Minot S, Bryson A, Chehoud C, Wu GD, Lewis JD, Bushman FD. 2013. Rapid evolution of the human gut virome. Proc. Natl. Acad. Sci. U. S. A. 110:12450-12455. http://dx.doi.org/10.1073/pnas.1300833110.
58. Erdmann S, Garrett RA. 2012. Selective and hyperactive uptake of foreign DNA by adaptive immune systems of an archaeon via two distinct mechanisms. Mol. Microbiol. 85:1044-1056. http://dx.doi.org/10.1111/j.1365- 2958.2012.08171.x.
59. Lillestøl RK, Shah SA, Brügger K, Redder P, Phan H, Christiansen J, Garrett RA. 2009. CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and dynamic properties. Mol. Microbiol. 72: 259-272. http://dx.doi.org/10.1111/j.1365-2958.2009.06641.x.
60. Horvath P, Romero DA, Coûté-Monvoisin AC, Richards M, Deveau H, Moineau S, Boyaval P, Fremaux C, Barrangou R. 2008. Diversity, activity, and evolution of CRISPR loci in Streptococcus thermophilus. J. Bacteriol. 190:1401-1412. http://dx.doi.org/10.1128/JB.01415-07.
61. Stabler RA, He M, Dawson L, Martin M, Valiente E, Corton C, Lawley TD, Sebaihia M, Quail MA, Rose G, Gerding DN, Gibert M, Popoff MR, Parkhill J, Dougan G, Wren BW. 2009. Comparative genome and phenotypic analysis of Clostridium difficile 027 strains provides insight into the evolution of a hypervirulent bacterium. Genome Biol. 10:R102. http://dx.doi.org/10.1186/gb-2009-10-9-r102.
62. Delaney N, Balenger S, Bonneaud C, Marx C, Hill G, Ferguson-Noel N, Tsai P, Rodrigo A, Edwards SV. 2012. Ultrafast evolution and loss of CRISPRs following a host shift in a novel wildlife pathogen, Mycoplasma gallisepticum. PLoS Genet. 8:e1002511. http://dx.doi.org/10.1371/ journal.pgen.1002511.
63. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, Trinh HT, Witney AA, Hinds J, Wren BW. 2006. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J. Bacteriol. 188:7297-7305. http://dx.doi.org/10.1128/ JB.00664-06.
64. Jiang W, Maniv I, Arain F, Wang Y, Levin BR, Marraffini LA. 2013. Dealing with the evolutionary downside of CRISPR immunity: bacteria and beneficial plasmids. PLoS Genet. 9:e1003844. http://dx.doi.org/ 10.1371/journal.pgen.1003844.
65. Goh S, Chang BJ, Riley TV. 2005. Effect of phage infection on toxin production by Clostridium difficile. J. Med. Microbiol. 54:129-135. http:// dx.doi.org/10.1099/jmm.0.45821-0.
66. Govind R, Vediyappan G, Rolfe RD, Dupuy B, Fralick JA. 2009. Bacteriophage-mediated toxin gene regulation in Clostridium difficile. J. Virol. 83:12037-12045. http://dx.doi.org/10.1128/JVI.01256-09.
67. Meader E, Mayer MJ, Gasson MJ, Steverding D, Carding SR, Narbad A. 2010. Bacteriophage treatment significantly reduces viable Clostridium difficile and prevents toxin production in an in vitro model system. Anaerobe 16:549-554. http://dx.doi.org/10.1016/j.anaerobe.2010.08.006.
68. Meader E, Mayer MJ, Steverding D, Carding SR, Narbad A. 2013. Evaluation of bacteriophage therapy to control Clostridium difficile and toxin production in an in vitro human colon model system. Anaerobe 22:25-30. http://dx.doi.org/10.1016/j.anaerobe.2013.05.001.
69. Zhou Y, Liang Y, Lynch KH, Dennis JJ, Wishart DS. 2011. PHAST: a fast phage search tool. Nucleic Acids Res. 39:W347-W352. http://dx.doi.org/ 10.1093/nar/gkq1255.
70. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer EL, Eddy SR, Bateman A, Finn RD. 2012. The Pfam protein families database. Nucleic Acids Res. 40:D290-D301. http://dx.doi.org/10.1093/ nar/gkr717.
71. Rutherford K, Parkhill J, Crook J, Horsnell T, Rice P, Rajandream MA, Barrell B. 2000. Artemis: sequence visualization and annotation. Bioinformatics 16:944 -945. http://dx.doi.org/10.1093/bioinformatics/ 16.10.944.
72. Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Söding J, Thompson JD, Higgins DG. 2011. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol. Syst. Biol. 7:539. http://dx.doi.org/ 10.1038/msb.2011.75.
73. Crooks GE, Hon G, Chandonia JM, Brenner SE. 2004. WebLogo: a sequence logo generator. Genome Res. 14:1188-1190. http://dx.doi.org/ 10.1101/gr.849004.
74. Schneider TD, Stephens RM. 1990. Sequence logos: a new way to display consensus sequences. Nucleic Acids Res. 18:6097-6100. http://dx.doi.org/ 10.1093/nar/18.20.6097.
75. Kumar S, Nei M, Dudley J, Tamura K. 2008. MEGA: a biologist-centric software for evolutionary analysis of DNA and protein sequences. Brief. Bioinform. 9:299-306. http://dx.doi.org/10.1093/bib/bbn017.
76. Biswas A, Gagnon JN, Brouns SJJ, Fineran PC, Brown CM. 2013. CRISPRTarget: bioinformatic prediction and analysis of crRNA targets. RNA Biol. 10:817-827. http://dx.doi.org/10.4161/rna.24046.
77. Tamura K, Stecher G, Peterson D, Filipski A, Kumar S. 2013. MEGA6: molecular evolutionary genetics analysis, version 6.0. Mol. Biol. Evol. 30: 2725-2729. http://dx.doi.org/10.1093/molbev/mst197.
78. Rozen S, Skaletsky H. 2000. Primer3 on theWWWfor general users and for biologist programmers. Methods Mol. Biol. 132:365-386.
79. Hargreaves KR, Colvin HV, Patel KV, Clokie JJ, Clokie MR. 2013. Genetically diverse Clostridium difficile strains harbouring abundant prophages in an estuarine environment. Appl. Environ. Microbiol. 79: 6236-6243. http://dx.doi.org/10.1128/AEM.01849-13.